TAŞYÜREK, M. H. Et Al. 2015. Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment. ESGCT and FSGCT Collaborative Congress,2015 , (Helsinki, Finland).

TAŞYÜREK, M. H., ALTUNBAŞ, H. A., CANATAN, H., & ŞANLIOĞLU, S., (2015). Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment . ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finland

TAŞYÜREK, MÜKERREM Et Al. "Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment," ESGCT and FSGCT Collaborative Congress,2015, Helsinki, Finland, 2015

TAŞYÜREK, MÜKERREM H. Et Al. "Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment." ESGCT and FSGCT Collaborative Congress,2015 , Helsinki, Finland, 2015

TAŞYÜREK, M. H. Et Al. (2015) . "Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment." ESGCT and FSGCT Collaborative Congress,2015 , Helsinki, Finland.

@conferencepaper{conferencepaper, author={MÜKERREM HALE TAŞYÜREK Et Al. }, title={Therapeutic outcomes of an HIV-based lentivirus mediated Glucagon-like peptide-1 gene delivery for diabetes treatment}, congress name={ESGCT and FSGCT Collaborative Congress,2015}, city={Helsinki}, country={Finland}, year={2015}}